Hepatitis Clinical Trials

GSK Investigational Site
Dothan Alabama 36305

Dose Ranging of GSK2336805 in Combination Therapy

Alabama Liver & Digestive Specialists (Alds)
Montgomery Alabama 36116

A clinical trial to evaluate treatments using Asunaprevir (BMS-650032) and/or Daclatasvir (BMS-790052) for patients with Hepatitis C

Maricopa Integrated Health System (MIHS)
Phoenix Arizona 85008
Updated

A clinical trial to evaluate treatments using ELAD treatment and Standard of care (Control) for patients with Acute Alcoholic Hepatitis

Phoenix Arizona

A clinical trial to evaluate treatments using Telaprevir, Peginterferon alfa-2b and Ribavirin for patients with Hepatitis C

Mayo Clinic Hospital
Phoenix Arizona 85054

A Phase 1 clinical study for patients with Hepatitis B or HBV

Mayo Clinic Arizona
Phoenix Arizona 85054

A Phase 3 clinical study for patients with Hepatitis C Virus (HCV)

Site Reference ID/Investigator# 70141
Tucson Arizona 85724

Patients are needed to participate in a clinical research study of ABT-450/r, ABT-267 and Ribavirin to evaluate Hepatitis C Virus

Anaheim Clinical Trials Llc
Anaheim California 92801

A Phase 3 clinical study for patients with Hepatitis C Virus

GSK Investigational Site
Anaheim California 92801

Dose Ranging of GSK2336805 in Combination Therapy

Call for Information (Investigational Site 0412)
Bakersfield California 93301

A clinical research study of peginterferon alfa-2a, ribavirin and boceprevir for the treatment of Hepatitis C, Chronic

Bakersfield California 93301

A Phase 2 clinical study for patients with Hepatitis C Virus

Franco Felizarta, MD
Bakersfield California 93301

Patients are needed to participate in a clinical research study evaluating Sofosbuvir, RBV and PEG for the treatment of Chronic Hepatitis C

Site Reference ID/Investigator# 72455
Bakersfield California 93301

Patients are needed to participate in a clinical research study of ABT-450/r, ABT-267 and Ribavirin to evaluate Hepatitis C Virus

Site Reference ID/Investigator# 103524
Bakersfield California 93301

Patients are needed to participate in a clinical research study of ABT-450/ritonavir, ABT-333 and ABT-267 to evaluate Hepatitis C

Call for Information (Investigational Site 0159)
Chula Vista California 91911

A clinical research study of peginterferon alfa-2a, ribavirin and boceprevir for the treatment of Hepatitis C, Chronic

Arrowhead Regional Medical Center
Colton California 92324

Patients are needed to participate in a clinical research study evaluating Sofosbuvir, RBV and PEG for the treatment of Chronic Hepatitis C

Southern California Transplantation Institute, Research Foundation Liver Center
Coronado California 92118

Patients are needed to participate in a clinical research study evaluating Sofosbuvir, RBV and PEG for the treatment of Chronic Hepatitis C

Site Reference ID/Investigator# 98415
Coronado California 92118

Patients are needed to participate in a clinical research study of ABT-450/r, ABT-267 and Ribavirin to evaluate Hepatitis C Virus

Site Reference ID/Investigator# 103530
Coronado California 92118

Patients are needed to participate in a clinical research study of ABT-450/ritonavir, ABT-333 and ABT-267 to evaluate Hepatitis C

West Coast Clinical Trials, LLC
Costa Mesa California 92626

A Phase 1 clinical study for patients with Hepatitis B or HBV

Wcct Global, Llc
Cypress California 90630

A clinical research study of Midazolam and BMS-791325 for the treatment of Hepatitis C

Call for Information (Investigational Site 0152)
Irvine California 92618

A clinical research study of peginterferon alfa-2a, ribavirin and boceprevir for the treatment of Hepatitis C, Chronic

1241.21.0003 Boehringer Ingelheim Investigational Site
La Jolla California
Updated

A clinical trial to evaluate treatments for patients with Hepatitis C, Chronic

Scripps Clinic
La Jolla California 92037

A clinical trial to evaluate treatments using Asunaprevir (BMS-650032) and/or Daclatasvir (BMS-790052) for patients with Hepatitis C

Scripps Clinic
La Jolla California 92037

A Phase 2 clinical study for patients with Hepatitis C Virus

Scripps Clinic
La Jolla California 92037

Patients are needed to participate in a clinical research study of Peginterferon Lambda-1a (BMS-914143) to evaluate Hepatitis C

1241.30.10003 Boehringer Ingelheim Investigational Site
La Mesa California
Updated

A clinical trial seeking patients for a research study for the treatment of Hepatitis C, Chronic

1241.27.0006 Boehringer Ingelheim Investigational Site
La Mesa California
Updated

A Phase 1 clinical study for patients with Hepatitis C, Chronic

eStudy Site
La Mesa California 91942

Patients are needed to participate in a clinical research study evaluating Sofosbuvir, RBV and PEG for the treatment of Chronic Hepatitis C

Call for Information (Investigational Site 0355)
Long Beach California 90813

A clinical research study of peginterferon alfa-2a, ribavirin and boceprevir for the treatment of Hepatitis C, Chronic

Long Beach California

A Phase 2 clinical study for patients with Hepatitis C

Va Long Beach Healthcare System
Long Beach California 90822

A Phase 3 clinical study for patients with Hepatitis C Virus

Call for Information (Investigational Site 0405)
Los Angeles California 90073

A clinical research study of peginterferon alfa-2a, ribavirin and boceprevir for the treatment of Hepatitis C, Chronic

Los Angeles California 90057

A clinical research study of Tenofovir alafenamide, Tenofovir DF, Placebo to match tenofovir alafenamide and Placebo to match tenofovir DF for the treatment of HBV or Chronic HBV Infections

Asian Pacific Liver Center at St. Vincent Medical Center
Los Angeles California 90057

A clinical trial seeking patients for a research study for the treatment of Hepatitis B

Southern California Permanente Medical Group
Los Angeles California 90027

A clinical trial seeking patients for a research study for the treatment of Hepatitis C, Genotype 1

Axis Clinical Trials
Los Angeles California 90036

A clinical trial to evaluate treatments using BMS-986094/INX-08189 and Placebo matching BMS-986094/INX-08189 for patients with Healthy or Hepatitis C

Keck Hospital of University of Southern California
Los Angeles California 90033
Updated

A clinical trial to evaluate treatments using ELAD treatment and Standard of care (Control) for patients with Acute Alcoholic Hepatitis

Los Angeles California

A Phase 2 clinical study for patients with Hepatitis C